R. Califano

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. G. Levra, Johan Vansteenkiste, Sanne A.E. Peters, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial.

A. Mansfield, F. Kabbinavar, C. Quach, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

J. Douillard, E. Cutsem, K. Fumasoli, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small cell lung cancer with a PD-L1 expression level of ≥ 1% by the U.S. Food and Drug Administration.

S. Novello, J. Vansteenkiste, T. Čufer, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. G. Levra, Johan Vansteenkiste, Sanne A.E. Peters, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.